GlassScriptPhysician profile
Paul Y Chung
NPI 1306953617
$1,042.91
in general payments reported to CMS, 2019-2025
11 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $122 · 2021: $144 · 2022: $184 · 2023: $145 · 2024: $134 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $388.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $278.37 | 2019-2021 | |
| Alcon Vision LLC | $235.85 | 2019-2024 | Hydrus Microstent, Clareon |
| Glaukos Corporation | $155.11 | 2021-2025 | Istent Infinite, Idosetr |
| Abbvie INC. | $109.19 | 2022-2025 | Liletta |
| Sight Sciences, INC. | $84.46 | 2021-2023 | Omni Surgical System |
| Allergan, INC. | $68.04 | 2019-2020 | |
| New World Medical,INC. | $35.82 | 2025 | Clearpath, Via360, Streamline |
| Rayner Intraocular Lenses Limited | $33.42 | 2024-2025 | Rayone Aspheric, Rayone Emv, Rayner Cataract Set 1 |
| Johnson & Johnson Surgical Vision, INC. | $14.96 | 2019 | |
| Aerie Pharmaceuticals, INC. | $14.20 | 2019 | |
| Bausch & Lomb Americas INC. | $13.49 | 2023 | Envista Mx60 Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Chung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.